TMEM212

gene
On this page

Also known as FLJ23172

Summary

TMEM212 (transmembrane protein 212, HGNC:34295) is a protein-coding gene on chromosome 3q26.31, encoding Transmembrane protein 212 (A6NML5).

Predicted to be located in membrane.

Source: NCBI Gene 389177 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 28 total
  • MANE Select transcript: NM_001164436

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:34295
Approved symbolTMEM212
Nametransmembrane protein 212
Location3q26.31
Locus typegene with protein product
StatusApproved
AliasesFLJ23172
Ensembl geneENSG00000186329
Ensembl biotypeprotein_coding
Entrez389177

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000334567, ENST00000420375, ENST00000450693, ENST00000469981, ENST00000619900, ENST00000905715

RefSeq mRNA: 1 — MANE Select: NM_001164436 NM_001164436

CCDS: CCDS46958

Canonical transcript exons

ENST00000334567 — 5 exons

ExonStartEnd
ENSE00001338950171851982171852041
ENSE00001338953171853527171853850
ENSE00001338957171843349171843542
ENSE00001530051171858061171859318
ENSE00001530052171856663171856707

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 97.09.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0454 / max 25.6867, expressed in 12 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
398010.045412

Top tissues by expression

196 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233697.09gold quality
bronchial epithelial cellCL:000232893.05gold quality
epithelium of bronchusUBERON:000203191.27gold quality
bronchusUBERON:000218590.69gold quality
right uterine tubeUBERON:000130289.94gold quality
tendon of biceps brachiiUBERON:000818887.95silver quality
mucosa of paranasal sinusUBERON:000503085.05gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.67gold quality
olfactory segment of nasal mucosaUBERON:000538683.13gold quality
cerebellar vermisUBERON:000472082.20silver quality
pancreatic ductal cellCL:000207979.93silver quality
spermCL:000001979.53silver quality
nasal cavity epitheliumUBERON:000538478.81gold quality
male germ cellCL:000001578.12silver quality
medial globus pallidusUBERON:000247777.35silver quality
globus pallidusUBERON:000187576.91silver quality
gluteal muscleUBERON:000200076.90gold quality
nasal cavity mucosaUBERON:000182676.51gold quality
vena cavaUBERON:000408776.22silver quality
pylorusUBERON:000116676.18silver quality
cardia of stomachUBERON:000116276.13silver quality
nippleUBERON:000203076.03silver quality
endothelial cellCL:000011575.76silver quality
tongue squamous epitheliumUBERON:000691975.17silver quality
inferior vagus X ganglionUBERON:000536374.94silver quality
superior surface of tongueUBERON:000737174.94silver quality
subthalamic nucleusUBERON:000190674.86silver quality
ventral tegmental areaUBERON:000269174.85silver quality
pericardiumUBERON:000240774.83silver quality
fallopian tubeUBERON:000388974.59gold quality

Single-cell (SCXA)

Detected in 11 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-GEOD-137537yes1041.48
E-CURD-89yes250.82
E-MTAB-5061yes14.68
E-ANND-3yes7.90
E-CURD-53no553.34
E-MTAB-10290no164.64
E-MTAB-7249no96.91
E-ENAD-20no63.12
E-GEOD-99795no14.09
E-GEOD-81547no4.80
E-CURD-112no2.63

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

69 targeting TMEM212, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3134100.0066.43777
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-371A-3P99.9966.7791
HSA-MIR-806899.9873.852376
HSA-MIR-477599.9875.006394
HSA-MIR-590-3P99.9674.346478
HSA-MIR-767-5P99.9570.85993
HSA-MIR-3140-3P99.8868.472069
HSA-MIR-10395-5P99.8667.35676
HSA-MIR-629-3P99.8567.991875
HSA-MIR-684499.8270.692423
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-4677-5P99.7070.091940
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-4649-3P99.5666.901783
HSA-MIR-6740-3P99.4868.491392
HSA-MIR-57899.4668.361787
HSA-MIR-6513-5P99.4367.811071
HSA-MIR-889-5P99.4168.751025
HSA-MIR-7151-5P99.3767.82613
HSA-MIR-135A-5P99.3671.851601
HSA-MIR-542-3P99.3467.581270
HSA-MIR-431299.3467.30511
HSA-MIR-4796-5P99.3470.06810
HSA-MIR-148A-5P99.3068.271141
HSA-MIR-133A-3P99.2771.531270
HSA-MIR-133B99.2771.531270

Literature-anchored findings (GeneRIF, showing 1)

  • The specialized function of this brain region suggests that TMEM212 could contribute to the innate architecture of face processing. (PMID:22828495)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusTmem212ENSMUSG00000043164
rattus_norvegicusTmem212ENSRNOG00000012608

Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)

Protein

Protein identifiers

Transmembrane protein 212A6NML5 (reviewed: A6NML5)

All UniProt accessions (3): A6NML5, H7C098, H7C390

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

RefSeq proteins (1): NP_001157908* (*=MANE)

Domains & families (InterPro)

UniProt features (6 total): transmembrane region 5, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NML5-F174.310.31

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 59 (showing top): XU_GH1_AUTOCRINE_TARGETS_UP, chr3q26, HARRIS_BRAIN_CANCER_PROGENITORS, JAK2_DN.V1_DN, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, FOXJ2_TARGET_GENES, ZNF274_TARGET_GENES, MIR8068, MIR578, MIR4782_5P, MIR5706, MIR6740_3P, MIR4424, MIR148A_5P, MIR6513_5P

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

636 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM212LINC03043A4D0Y5505
TMEM212TMEM221A6NGB7470
TMEM212TCF12Q99081450
TMEM212CFAP20DCQ6ZVT6447
TMEM212TSPAN19P0C672441
TMEM212PLEKHN1Q494U1435
TMEM212SLC24A3Q9HC58428
TMEM212ZNF396Q96N95420
TMEM212FAM216BQ8N7L0414
TMEM212SPATA18Q8TC71407
TMEM212SNTNA6NMZ2407
TMEM212DYNLT4Q5JR98403
TMEM212DYNLRB2Q8TF09403
TMEM212PTPDC1A2A3K4399
TMEM212MFAP3P55082397

IntAct

0 interactions, top by confidence:

BioGRID (2): TMEM212 (Affinity Capture-RNA), TMEM212 (Protein-RNA)

ESM2 similar proteins: A4IIU3, A6NML5, D3YWQ9, O75204, P0DP42, P11836, P20490, P56749, Q01362, Q0IIL2, Q2KJ11, Q2YDM3, Q32KQ5, Q3T110, Q3YBM2, Q497B3, Q4G068, Q504G0, Q5EB63, Q5FWC3, Q5HYL7, Q5M962, Q5R8D6, Q5R9K1, Q5RCD5, Q5RFC1, Q6GV28, Q7T392, Q7TQI0, Q7YQI4, Q8BGP5, Q8BHH8, Q8C6V3, Q8K177, Q8NCR9, Q8VHW1, Q8WXS4, Q920C4, Q925D4, Q940P5

Diamond homologs: A6NML5, Q8C6V3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

28 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance27
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

459 predictions. Top by Δscore:

VariantEffectΔscore
3:171843439:GT:Gdonor_gain0.9900
3:171853851:G:GGdonor_gain0.9800
3:171843499:G:GTdonor_gain0.9400
3:171852108:G:GTdonor_gain0.9400
3:171843450:G:GTdonor_gain0.9300
3:171851271:G:GTdonor_gain0.9300
3:171845754:TCAA:Tdonor_gain0.9200
3:171843535:GAGCT:Gdonor_gain0.9100
3:171853521:TTTCA:Tacceptor_loss0.9100
3:171853522:TTCA:Tacceptor_loss0.9100
3:171853523:TCAGG:Tacceptor_loss0.9100
3:171853524:CAGGG:Cacceptor_loss0.9100
3:171853526:G:GAacceptor_loss0.9100
3:171853850:CGTAA:Cdonor_loss0.9100
3:171853851:GTA:Gdonor_loss0.9100
3:171853852:TAAG:Tdonor_loss0.9100
3:171853853:A:AGdonor_loss0.9100
3:171853854:AGTTT:Adonor_loss0.9100
3:171843543:G:GGdonor_gain0.9000
3:171852046:A:Gdonor_gain0.9000
3:171853525:AG:Aacceptor_gain0.9000
3:171853526:GG:Gacceptor_gain0.9000
3:171843540:TTG:Tdonor_loss0.8900
3:171843541:TGG:Tdonor_loss0.8900
3:171843542:GGTA:Gdonor_loss0.8900
3:171843543:G:Tdonor_loss0.8900
3:171843544:T:Adonor_loss0.8900
3:171853855:G:Cdonor_loss0.8900
3:171853525:AGG:Aacceptor_gain0.8700
3:171853526:GGG:Gacceptor_gain0.8700

AlphaMissense

1237 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:171853773:A:CS156R0.922
3:171853775:C:AS156R0.922
3:171853775:C:GS156R0.922
3:171843438:A:CS19R0.914
3:171843440:T:AS19R0.914
3:171843440:T:GS19R0.914
3:171843492:T:CF37L0.914
3:171843494:C:AF37L0.914
3:171843494:C:GF37L0.914
3:171843462:T:CF27L0.911
3:171843464:C:AF27L0.911
3:171843464:C:GF27L0.911
3:171853557:A:CS84R0.911
3:171853559:C:AS84R0.911
3:171853559:C:GS84R0.911
3:171843465:T:CF28L0.859
3:171843467:T:AF28L0.859
3:171843467:T:GF28L0.859
3:171843504:A:CS41R0.856
3:171843506:T:AS41R0.856
3:171843506:T:GS41R0.856
3:171843528:T:AW49R0.851
3:171843528:T:CW49R0.851
3:171843485:G:CK34N0.847
3:171843485:G:TK34N0.847
3:171843429:G:TG16W0.834
3:171843429:G:AG16R0.825
3:171843429:G:CG16R0.825
3:171853569:T:CC88R0.811
3:171853581:T:CF92L0.808

dbSNP variants (sampled 300 via entrez): RS1000143828 (3:171847927 T>C), RS1000253748 (3:171844978 G>A), RS1000306591 (3:171859196 T>C), RS1000533364 (3:171852929 G>A), RS1000790234 (3:171847441 T>C,G), RS1000810723 (3:171855445 T>A), RS1000946279 (3:171855069 T>C), RS1001049716 (3:171853173 C>A), RS1001139185 (3:171851173 A>G), RS1001226342 (3:171845066 C>T), RS1001275101 (3:171850854 C>T), RS1001367436 (3:171849950 C>G), RS1001437435 (3:171843511 G>A,C,T), RS1001483704 (3:171857006 T>C), RS1002158597 (3:171845422 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST000821_15Bipolar disorder and schizophrenia6.000000e-07
GCST001125_1Body mass index2.000000e-06
GCST001520_6Response to angiotensin II receptor blocker therapy4.000000e-07
GCST003059_6Parkinson’s disease1.000000e-06
GCST006138_39Resting-state electroencephalogram vigilance2.000000e-06
GCST011390_2Corneal resistance factor5.000000e-66
GCST011946_25White matter hyperintensity volume1.000000e-05
GCST011947_9White matter hyperintensity volume4.000000e-06
GCST011949_42White matter hyperintensity volume (adjusted for hypertension)4.000000e-06
GCST011950_37White matter hyperintensity volume (adjusted for hypertension)2.000000e-06
GCST011952_26White matter hyperintensity volume x hypertension interaction (2df)6.000000e-06
GCST011953_19White matter hyperintensity volume x hypertension interaction (2df)3.000000e-06
GCST90013442_5Keratoconus1.000000e-26

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004357electroencephalogram measurement
EFO:0010067corneal resistance factor
EFO:0005665white matter hyperintensity measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsincreases expression, increases abundance2
fipronildecreases expression, affects cotreatment1
jinfukangdecreases expression1
Decitabineincreases expression1
DEETaffects cotreatment, decreases expression1
Formaldehydeincreases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1decreases methylation1
Cadmium Chlorideincreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mental disorder